Cheng Fang-Shu, Pan Dan, Chang Bing, Jiang Min, Sang Li-Xuan
Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
Department of Geriatrics, the First Affiliated Hospital, China Medical University, Shenyang 110001, Liaoning Province, China.
World J Clin Cases. 2020 Apr 26;8(8):1361-1384. doi: 10.12998/wjcc.v8.i8.1361.
Probiotics are known as "live microorganisms" and have been proven to have a health effect on hosts at the proper dose. Recently, a kind of probiotic mixture including eight live bacterial strains, VSL#3, has attracted considerable attention for its combined effect. VSL#3 is the only probiotic considered as a kind of medical food; it mainly participates in the regulation of the intestinal barrier function, including improving tight junction protein function, balancing intestinal microbial composition, regulating immune-related cytokine expression and so on. The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans (including children). We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies, including digestive systemic diseases (gastrointestinal diseases and hepatic diseases), obesity and diabetes, allergic diseases, nervous systemic diseases, atherosclerosis, bone diseases, and female reproductive systemic diseases.
益生菌被称为“活的微生物”,并且已被证明在适当剂量下对宿主具有健康效应。最近,一种包含八种活菌株的益生菌混合物VSL#3因其综合作用而备受关注。VSL#3是唯一被视为一种医用食品的益生菌;它主要参与肠道屏障功能的调节,包括改善紧密连接蛋白功能、平衡肠道微生物组成、调节免疫相关细胞因子表达等。本综述的目的是探讨VSL#3在动物和人类(包括儿童)慢性病中的治疗作用及机制。我们发现,大量研究表明VSL#3在各种全身性疾病中具有治疗或预防作用,包括消化系统疾病(胃肠疾病和肝脏疾病)、肥胖症和糖尿病、过敏性疾病、神经系统疾病、动脉粥样硬化、骨骼疾病以及女性生殖系统疾病。